Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
PaperCitations, authors & open-access status
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 262 citations, 2016 year and hybrid oa status.
262
Citations
2016
Year
hybrid
OA Status